Back to Search
Start Over
The Impact of an 8-Week Supplementation with Fermented and Non-Fermented Aronia Berry Pulp on Cardiovascular Risk Factors in Individuals with Type 2 Diabetes.
- Source :
-
Nutrients [Nutrients] 2023 Dec 13; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 13. - Publication Year :
- 2023
-
Abstract
- Aronia berries contain antioxidants that may be health-promoting, e.g., demonstrated positive effects on hypertension and dyslipidaemia. There is a close link between cardiovascular diseases and hypertension and dyslipidaemia, and cardiovascular events are the leading cause of death among subjects with type 2 diabetes (T2D). Thus, we investigated the effect of an 8-week supplementation with fermented aronia extract (FAE), non-fermented aronia extract (AE), and placebo on cardiovascular risk factors. Snack bars were produced containing 34 g (37%) aronia extract, or 17 g (21%) wheat bran for placebo, as well as raisins and coconut oil. The study was randomized and blinded with a triple-crossover design. We examined the effects of aronia extracts on blood pressure, adiponectin, and high-sensitive C-reactive protein, and found no effects. After supplementation with placebo, there were significantly higher blood concentrations of total cholesterol, LDL-cholesterol, and HDL-cholesterol, with the placebo group showing significantly higher increases in total cholesterol and LDL-cholesterol than the AE group. Furthermore, we observed an increase in HDL-cholesterol in the FAE group and an increase in triglyceride in the AE group. Thus, we assume that the raisins may have increased the participants' cholesterol levels, with both AE and FAE having the potential to prevent this increase.
- Subjects :
- Humans
Fruit
Plant Extracts pharmacology
Plant Extracts therapeutic use
Risk Factors
Cholesterol, LDL
Cholesterol, HDL
Dietary Supplements
Heart Disease Risk Factors
Cardiovascular Diseases etiology
Cardiovascular Diseases prevention & control
Photinia
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 drug therapy
Hypertension drug therapy
Dyslipidemias drug therapy
Dyslipidemias complications
Subjects
Details
- Language :
- English
- ISSN :
- 2072-6643
- Volume :
- 15
- Issue :
- 24
- Database :
- MEDLINE
- Journal :
- Nutrients
- Publication Type :
- Academic Journal
- Accession number :
- 38140354
- Full Text :
- https://doi.org/10.3390/nu15245094